
US Food and Drug Administration staff are bracing for a sweeping shift in vaccine oversight after Vinay Prasad, head of the agency’s Center for Biologics Evaluation and Research (CBER), said the agency will regulate vaccines in the same way it regulates other drug classes.
The internal note, prompted by an analysis he says ties at least ten child deaths to COVID-19 shots, marks the most dramatic intervention by a senior official since Robert Kennedy Jr became Health and Human Services Secretary (HHS) in January.
In the memo, Dr Prasad claimed that “no fewer than 10” deaths among 96 reports submitted to the Vaccine Adverse Event Reporting System (VAERS) between 2021 and 2024 were related to vaccination, while arguing the true total could be higher. He offered no clinical details, timelines or manufacturer information, and the findings have not been peer-reviewed.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze